Trial Profile
Randomized Phase II Trial Evaluating [Radiotherapy-Docetaxel-5 Fluorouracil] Association Versus [Radiotherapy-Docetaxel-Cisplatin] Association in Non Resecables First Line of Chemotherapy in Metastatics Pancreas Cancers Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms ACCORD-09
- 15 Feb 2021 Status changed from active, no longer recruiting to completed.
- 22 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Aug 2005 New trial record.